Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients (Q40569350)

21 September 2017

title

Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients (English)

1 reference

21 September 2017

1

1 reference

21 September 2017

3

Ronald J A Wanders

1 reference

21 September 2017

Marit S Schneiders

2

1 reference

21 September 2017

Hans R Waterham

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

10 December 2002

1 reference

Journal of Biological Chemistry

21 September 2017

published in

1 reference

21 September 2017

volume

278

1 reference

21 September 2017

issue

8

1 reference

21 September 2017

page(s)

5736-5743

1 reference

Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Mevalonic aciduria--an inborn error of cholesterol and nonsterol isoprene biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Regulation of the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Farnesol as a regulator of HMG-CoA reductase degradation: characterization and role of farnesyl pyrophosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, AND RhoB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

Farnesol is utilized for protein isoprenylation and the biosynthesis of cholesterol in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206564200

21 January 2018

Identifiers

DOI

10.1074/JBC.M206564200

1 reference

21 September 2017

1 reference